(Q35781657)

10 August 2017

Microbiome and pediatric atopic dermatitis (English)

1 reference

10 August 2017

0 references

Claire E Powers

1

1 reference

10 August 2017

Diana B McShane

2

1 reference

10 August 2017

Peter H Gilligan

3

1 reference

10 August 2017

Craig N Burkhart

4

1 reference

10 August 2017

Dean S Morrell

5

1 reference

10 August 2017

language of work or name

1 reference

21 September 2015

1 reference

The Journal of Dermatology

10 August 2017

1 reference

10 August 2017

42

1 reference

10 August 2017

12

1 reference

10 August 2017

1137-1142

1 reference

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

New insights into the epidemiology of childhood atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

The burden of atopic dermatitis: impact on the patient, family, and society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

The socioeconomic impact of atopic dermatitis in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Topographical and temporal diversity of the human skin microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Filaggrin mutations associated with skin and allergic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Staphylococcus epidermidis--the 'accidental' pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Cutaneous defense mechanisms by antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Endogenous antimicrobial peptides and skin infections in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Compartmentalized control of skin immunity by resident commensals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Developmental cytokine response profiles and the clinical and immunologic expression of atopy during the first year of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Allergy development and the intestinal microflora during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Pre- and post-natal exposure to antibiotics and the development of eczema, recurrent wheezing and atopic sensitization in children up to the age of 4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Association between attendance of day care centres and increased prevalence of eczema in the German birth cohort study LISAplus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Day-care attendance and increased risk for respiratory and allergic symptoms in preschool age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Endotoxin exposure and eczema in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Exposure to endotoxin decreases the risk of atopic eczema in infancy: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Endotoxin exposure, wheezing, and rash in infancy in a New Zealand birth cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Early endotoxin exposure and atopy development in infants: results of a birth cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Mode of delivery and development of atopic disease during the first 2 years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Reduced diversity in the early fecal microbiota of infants with atopic eczema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Gut microbiota and development of atopic eczema in 3 European birth cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Superantigens in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Atopic dermatitis: new insights and opportunities for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

The cutaneous reaction to staphylococcal protein A in normal subjects and patients with atopic dermatitis or psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

The role of Malassezia in atopic dermatitis affecting the head and neck of adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Lactobacillus rhamnosus GG inhibits the toxic effects of Staphylococcus aureus on epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

"Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Lactobacillus salivarius plus fructo-oligosaccharide is superior to fructo-oligosaccharide alone for treating children with moderate to severe atopic dermatitis: a double-blind, randomized, clinical trial of efficacy and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1346-8138.13072

21 January 2018

Identifiers

DOI

10.1111/1346-8138.13072

1 reference

10 August 2017

1 reference